Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 11.20% vs -16.89% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 25.15% vs -7.03% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 53.62% vs 245.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -6.01% vs 4.43% in Mar 2024
Compare Balance Sheet Results of Aarey Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
28.45
15.74
12.71
80.75%
Share Warrants & Outstandings
Total Reserve
107.51
35.76
71.75
200.64%
Shareholder's Funds
138.48
51.50
86.98
168.89%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
1.99
1.99
0.00
0.00%
Secured Loans
1.99
0.00
1.99
0.00%
Unsecured Loans
0.00
1.99
-1.99
-100.00%
Deferred Tax Assets / Liabilities
0.92
-0.71
1.63
229.58%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
2.91
1.28
1.63
127.34%
Current Liabilities
Trade Payables
102.54
4.18
98.36
2,353.11%
Other Current Liabilities
11.07
2.14
8.93
417.29%
Short Term Borrowings
32.87
3.93
28.94
736.39%
Short Term Provisions
2.73
0.00
2.73
0.00%
Total Current Liabilities
149.21
10.25
138.96
1,355.71%
Total Liabilities
290.59
63.03
227.56
361.03%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
39.10
5.92
33.18
560.47%
Less: Accumulated Depreciation
22.88
0.00
22.88
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
16.22
5.92
10.30
173.99%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.28
-0.28
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
2.12
0.82
1.30
158.54%
Long Term Loans & Advances
6.64
1.35
5.29
391.85%
Other Non Current Assets
0.01
0.00
0.01
0.00%
Total Non-Current Assets
24.98
8.37
16.61
198.45%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
45.48
4.56
40.92
897.37%
Sundry Debtors
133.46
5.98
127.48
2,131.77%
Cash and Bank
1.47
30.70
-29.23
-95.21%
Other Current Assets
0.78
6.94
-6.16
-88.76%
Short Term Loans and Advances
84.41
6.48
77.93
1,202.62%
Total Current Assets
265.61
54.66
210.95
385.93%
Net Current Assets (Including Current Investments)
116.40
44.41
71.99
162.10%
Total Current Assets Excluding Current Investments
265.61
54.66
210.95
385.93%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
290.59
63.03
227.56
361.03%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
34.86
5.92
28.94
488.85%
Book Value per share (adjusted)
46.90
32.71
14.19
43.38%
Annual - Borrowings
Borrowings 34.86 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.20% vs -16.89% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 16.22 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 25.15% vs -7.03% in Mar 2024
Annual - Investments
Investments 2.12 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 53.62% vs 245.00% in Mar 2024
Annual - Current Assets
Current Assets 265.61 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.01% vs 4.43% in Mar 2024






